Search results

From Self-sufficiency
Jump to: navigation, search
  • ...ayed [[cerebral ischemia]] is a major contributor to post-operative stroke and death especially after aneurysmal [[subarachnoid space|subarachnoid]] hemor ...e smooth muscle cells. However, aggregating platelets also stimulate TXA-2 and 5-HT which can induce contraction of the smooth muscle cells. In general t
    7 KB (957 words) - 21:27, 21 September 2010
  • ...tissue. Ischemia results in tissue damage because of a lack of [[oxygen]] and nutrients [http://www.ncbi.nlm.nih.gov/pubmed/19751827]. Ultimately, this c ...flow and force the blood to the extremities of the body, as in acrobatics and military flying
    8 KB (1,062 words) - 21:28, 21 September 2010
  • '''''[[Cardiovascular]]:''''' '''''[[Ear]], [[nose]], and [[throat]]:'''''
    30 KB (4,151 words) - 22:14, 21 September 2010
  • ...ac is available and is used to treat eye pain and to relieve the itchiness and burning of seasonal [[Allergy|allergies]].The FDA has approved an intranasa ...ism of action]] responsible for ketorolac's anti-inflammatory, antipyretic and analgesic effects is the inhibition of prostaglandin synthesis by competiti
    16 KB (2,012 words) - 22:15, 21 September 2010
  • | pregnancy_category = B (1st. and 2nd. trimenon), X (third trimenon) ...some countries. Manufacture and veterinary use is banned in India, Nepal and Pakistan due to imminent extinction of local vultures.
    28 KB (3,886 words) - 22:16, 21 September 2010
  • ...wer concentrations of prostaglandins. As a consequence, inflammation, pain and fever are reduced. The FDA approved etodolac in January 1991.<ref name="med ...]s." Unlike rofecoxib, both etodolac and celecoxib can fully inhibit COX-1 and are designated as having "preferential selectivity" toward COX-2. Interesti
    8 KB (1,051 words) - 22:16, 21 September 2010
  • ...ase in the risk for [[myocardial infarction|heart attack]], [[thrombosis]] and [[stroke]] by a relative increase in [[thromboxane]]. [[Rofecoxib]] (common {{details|Discovery and development of cyclooxygenase 2 inhibitors}}
    30 KB (4,194 words) - 22:17, 21 September 2010
  • ...on|drug]]s with [[analgesic]] and [[antipyretic]] (fever-reducing) effects and which have, in higher doses, [[anti-inflammatory]] effects. The term "nonsteroidal" is used to distinguish these drugs from [[steroids]], which - among a broad range of other effects - have a si
    35 KB (4,649 words) - 22:18, 21 September 2010
  • | routes_of_administration = [[Intravenous therapy|Intravenous]] ...rinary medicine]]. Propofol is approved for use in more than 50 countries, and [[generic drug|generic]] versions are available.
    21 KB (2,875 words) - 21:03, 24 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)